Sensill

Sensill is developing a novel diagnostic technology system based on a proven approach to sensing infection by identifying and quantifying the bacterial and fungal pathogens that cause skin, wound, and urine infections. The company's point-of-care platform detects volatile organic compounds (VOCs) emitted by infectious microorganisms to enable rapid, non-invasive diagnosis and to monitor patient response to therapy. Sensill is led by CEO Dr. Ardeshir Bayat, an internationally recognized translational scientist, alongside a leadership team with deep medical device and diagnostics experience.